Therefore, this study aims to investigate the role of METTL3-mediated m6A RNA methylation modification in the autophagy of ischemic and hypoxic cardiomyocytes, and explore the mechanism of m6A modification involved in ischemic heart diseases. This evidence concerns the gene METTL3 and coronary artery disorder.